BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31034023)

  • 21. What Matters to Parents Regarding Immunization of Their Children: Systematic Analysis of Expert Advice to Parents in an Internet Forum.
    Imahorn N; Heininger U
    Pediatr Infect Dis J; 2020 Feb; 39(2):157-163. PubMed ID: 31725113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A perspective on controlling vaccine-preventable diseases among children in Liberia.
    Weeks RM
    Infect Control; 1984 Nov; 5(11):538-41. PubMed ID: 6568218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global Routine Vaccination Coverage, 2018.
    Peck M; Gacic-Dobo M; Diallo MS; Nedelec Y; Sodha SV; Wallace AS
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(42):937-942. PubMed ID: 31647786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization Update VI.
    Mirza A; Rathore MH
    Adv Pediatr; 2017 Aug; 64(1):13-25. PubMed ID: 28688586
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccine Preventable Disease and Vaccine Hesitancy.
    Hotez PJ
    Med Clin North Am; 2023 Nov; 107(6):979-987. PubMed ID: 37806729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization issues for the 21st century.
    Frenkel LD; Nielsen K
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6 Suppl 3):45-52. PubMed ID: 12839113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global routine vaccination coverage, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(42):1367-71. PubMed ID: 21030941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009-12.
    Sharma A; Kaplan WA; Chokshi M; Zodpey SP
    Health Policy Plan; 2016 Sep; 31(7):884-96. PubMed ID: 26976803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Addressing common barriers in adult immunizations: a review of interventions.
    Bach AT; Kang AY; Lewis J; Xavioer S; Portillo I; Goad JA
    Expert Rev Vaccines; 2019 Nov; 18(11):1167-1185. PubMed ID: 31791159
    [No Abstract]   [Full Text] [Related]  

  • 31. New immunization strategies: adapting to global challenges.
    Mantel C; Cherian T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):25-31. PubMed ID: 31802153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric immunizations.
    Edwards KM
    Curr Probl Pediatr; 1993; 23(5):186-209. PubMed ID: 8354078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shifts in global immunisation goals (1984-2004): unfinished agendas and mixed results.
    Hardon A; Blume S
    Soc Sci Med; 2005 Jan; 60(2):345-56. PubMed ID: 15522490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded programme on immunization.
    Keja K; Chan C; Hayden G; Henderson RH
    World Health Stat Q; 1988; 41(2):59-63. PubMed ID: 3176515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of vaccine-preventable diseases, trends in vaccine coverage and current challenges in the implementation of the expanded program on immunization: A situation analysis of Cameroon.
    Ngwa CH; Doungtsop BK; Bihnwi R; Ngo NV; Yang NM
    Hum Vaccin Immunother; 2022 Dec; 18(1):1939620. PubMed ID: 34197271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasible improvements in vaccines in the Expanded Programme on Immunization.
    McIntosh K
    Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization and vaccine-preventable illness, United States, 1992 to 1997.
    Teitelbaum MA; Edmunds M
    Stat Bull Metrop Insur Co; 1999; 80(2):13-20. PubMed ID: 10327522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postneonatal mortality impacts following grants from the Gavi Vaccine Alliance: an econometric analysis from 2000 to 2014.
    Kolesar RJ; Audibert M
    Public Health; 2017 Dec; 153():163-171. PubMed ID: 29102832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.